| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |